While c-MET protein overexpression is frequently observed in various cancers and linked to poor prognosis, its functional relevance in the absence of a genomic alteration (like gene amplification or mutation) remains a subject of ongoing research and is not fully understood, through either paracrine or autocrine signaling, the pathway is important for breast cancer progression. This evidence concerns the gene MET and breast carcinoma.